Menu
Meet the Programme Commitee for 2020!
Program Committee
-
Mathieu Boudes, PhD • Patient Engagement Director
Montsouris Consilium, France -
Sini Eskola, MPharm, MS, MSc • Director Regulatory Strategy
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium -
Sabine Haubenreisser, PhD, MSc • Principal Scientific Administrator, Stakeholders and Communication Division
European Medicines Agency, Netherlands -
Lenita Lindström, LLM • ICH Assembly Chair and Senior Expert, European Commission
European Commission, Belgium -
Kristin Raudsepp, MD • Head of the Tartu Raatuse Clinic
Confido Medical Center, Estonia -
Thomas Senderovitz, DrMed, MD • Senior Vice President, Data Science
NovoNordisk, Denmark -
Chris Walker, MSc • VP, Head of Regulatory Affairs (EU,LATAM,MiddleEast,Africa,CAN)
Amgen, United Kingdom -
Sabine Atzor, MPharm, RPh • Head of EU Regulatory Policies
F. Hoffmann-La Roche Ltd, Switzerland -
Michael Berntgen, PhD • Head of Scientific Evidence Generation
European Medicines Agency, Netherlands -
Michelle Bridenbaker, BSN, MS • Vice-President at MILE, Head of Global Medical Information,
Recordati Rare Disease, Switzerland -
Nikolai Constantin Brun, MD • Co-Chair, EMA-MHA Big Data Task Force; Dir, Div for Medical Eval & Biostatistics
Danish Medicines Agency, Denmark -
Ursula Busse, PhD, MBA • Head of Regulatory Affairs
Tigen Pharma SA, Switzerland -
Tony Humphreys, MPharm • Head of the Regulatory Science and Innovation Task Force
European Medicines Agency, Netherlands -
Claudio Lorck, DrSc • Associate Director Regulatory Policy & Intelligence
Abbvie Deutschland GmbH, Germany -
Katarzyna Swiderek, MPharm, RPh • Director, Safety Evaluation Risk Management (SERM)
GlaxoSmithKline, Poland -
Elena Prokofyeva, MD, PhD, MPH • Head of Drug Safety Unit, Department of Research & Development, DG PRE
Federal Agency for Medicines and Health Products (FAMHP), Belgium -
Anja Schiel, PhD • Special Advisor, Lead Methodologist; Leader international HTA (iHTA) NoMA
Norwegian Medicines Agency (NoMA), Norway -
Gerhard Schlueter, DrSc, MSc • Head of Strategic and Technical Operations, Regulatory Affairs
Bayer AG, Germany -
Elke Stahl, PhD • Senior Expert, Clinical Trials Department
Federal Institute For Drugs and Medical Devices (BfArM), Germany -
Aimad Torqui • Division Head Medicines Evaluation Board
Medicines Evaluation Board, Netherlands -
Timothy Wilsdon, MS • Principal
Charles River Associates International, United Kingdom -
Maria Wishart • Medical Director, Global Patient Safety
Astrazeneca, United Kingdom